Document is current
Any future updates will be listed below
-
Authors
Laurent, Michaël R.
Samaey, Pieter
Javaid, M. Kassim
- License Information
-
More Information
Article History
Received: 4 December 2025
Accepted: 21 March 2026
First Online: 29 March 2026
Declarations
:
: This manuscript does not contain clinical studies or patient data; ethics approval was not applicable.
: MRL has received consultancy and lecture fees from Alexion, A.M. Pharma, Amgen, AstraZeneca, Celltrion, Galapagos, Kyowa Kirin, Menarini, Orifarm, Pharmanovia, Samsung Bioepis, Sandoz, Takeda, Theramex, UCB Pharma, and Will Pharma, outside of the development of this manuscript. PS has received consultancy fees from Amgen, UCB Pharma, and Will Pharma, outside of the development of this manuscript. MKJ is the FAN Steering Committee Co-Chair, has been the co-chair of the Capture the Fracture® programme, and has received honoraria and grant support from Amgen, UCB Pharma, and Kyowa Kirin outside of the development of this manuscript.The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health.
